Dataset Information


Effects of restrictive red blood cell transfusion on the prognoses of adult patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials.

ABSTRACT: Restrictive red blood cell transfusion strategies remain controversial in patients undergoing cardiac surgery. We performed a meta-analysis to assess the prognostic benefits of restrictive red blood cell transfusion strategies in patients undergoing cardiac surgery.We identified randomized clinical trials through the 9th of December 2017 that investigated a restrictive red blood cell transfusion strategy versus a liberal transfusion strategy in patients undergoing cardiac surgery. Individual patient data from each study were collected. Meta-analyses were performed for the primary and secondary outcomes. The risk of bias was assessed using the Cochrane Risk of Bias Tool. A trial sequential analysis (TSA)-adjusted random-effects model was used to pool the results from the included studies for the primary outcomes.Seven trials involving a total of 8886 patients were included. The TSA evaluations suggested that this meta-analysis could draw firm negative results, and the data were sufficient. There was no evidence that the risk of 30-day mortality differed between the patients assigned to a restrictive blood cell transfusion strategy and a liberal transfusion strategy (odds ratio (OR) 0.98; 95% confidence interval (CI) 0.77 to 1.24; p?=?0.87). Furthermore, the study suggested that the restrictive transfusion strategy was not associated with significant increases in pulmonary morbidity (OR 1.09; 95% CI 0.88 to 1.34; p?=?0.44), postoperative infection (OR 1.11; 95% CI 0.95 to 1.3; p?=?0.58), acute kidney injury (OR 1.03; 95% CI 0.92 to 1.14; p?=?0.71), acute myocardial infarction (OR 1.01; 95% CI 0.80 to 1.27; p?=?0.78), or cerebrovascular accidents (OR 0.97; 95% CI 0.72 to 1.30; p?=?0.66).Our meta-analysis demonstrates that the restrictive red blood cell transfusion strategy was not inferior to the liberal strategy with respect to 30-day mortality, pulmonary morbidity, postoperative infection, cerebrovascular accidents, acute kidney injury, or acute myocardial infarction, and fewer red blood cells were transfused.


PROVIDER: S-EPMC5977455 | BioStudies | 2018-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4549631 | BioStudies
2014-01-01 | S-EPMC4289152 | BioStudies
2011-01-01 | S-EPMC3268062 | BioStudies
2015-01-01 | S-EPMC4443456 | BioStudies
2015-01-01 | S-EPMC4372223 | BioStudies
2019-01-01 | S-EPMC6659290 | BioStudies
2017-01-01 | S-EPMC5848498 | BioStudies
2018-01-01 | S-EPMC5770109 | BioStudies
2020-01-01 | S-EPMC7045194 | BioStudies
2016-01-01 | S-EPMC4817242 | BioStudies